23Strands logo — 23Strands is unlocking the power of your DNA

23Strands

23Strands is unlocking the power of your DNA

Founded 2018 Australia Australia 29 employees Seed Total: $10.00K AI, Big Data +3

General Information

Company Name 23Strands
Founded Year 2018
Location Australia Australia +1
Employees 29
Industries AI, Big Data, Biotechnology +2
Funding Stage Seed
Social

Get notified when 23Strands moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About 23Strands

23Strands, with its slogan "23Strands is unlocking the power of your DNA," is an Australia-based startup leveraging advancements in AI, Big Data, Biotechnology, Health Care, and Machine Learning to innovate in the realm of genetic analysis.

Founded in 2018, the company aims to redefine Whole Human Genome Sequencing (WHGS) by integrating clinical insights with medical records through Artificial Intelligence. This approach seeks to empower specialists, general practitioners, and patients by providing evidence-based healthcare recommendations.

Their technology capitalizes on big data processing breakthroughs to deliver trustworthy insights for improving long-term health outcomes.

The company's most recent financial activity was a $10.00K seed investment dated 01 September 2020, sourced from the 10x Accelerator - UNSW.

Taxonomy: Whole Human Genome Sequencing, Genomics, Integrated Medical Records, Health Improvements, Clinical Insights, Big Data Processing, Evidence-based Recommendations, Personalized Medicine, Disease Risk Assessment, Medication Optimization, Healthcare Innovation, Genetic Testing, DNA Analysis

Services & Products

Whole Genome Sequencing
Genomic Health Analysis
Fertility23 Program
Medical Record Integration
Precision Health Insights
Concierge Health Pathway

Target Customers

Clinicians Healthcare Providers Patients with Unexplained Infertility Reproductive Health Specialists Medical Researchers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 1 •••• •••• 01 Sep 2020

23Strands Alternatives & Competitors

23Strands vs
GenEmbryomics
GenEmbryomics United States

Genome sequencing of IVF embryos

Seed
6 employees
Biotechnology, Health Care
23Strands vs

Avrio Genetics offers a single-cell whole genome sequencing service utilizing its patented MALBAC si...

Health Care
23Strands vs

Whole-genome analysis and clinical reporting. CapeDx for cancer patients, GulfDx for inherited disea...

4 employees
Biotechnology
Also compare with: 23Strands vs DELFI Diagnostics DELFI Diagnostics

FAQ About 23Strands

23Strands is unlocking the power of your DNA
23Strands was founded in 2018.
23Strands is headquartered in Australia.
23Strands operates in the following industries: AI, Big Data, Biotechnology, Health Care, Machine Learning.
23Strands has approximately 29 employees.
23Strands has completed 1 funding round, raising a total of $10.00K. The latest funding stage is Seed.
23Strands offers: Whole Genome Sequencing, Genomic Health Analysis, Fertility23 Program, Medical Record Integration, Precision Health Insights, Concierge Health Pathway.
Top alternatives and competitors to 23Strands include GenEmbryomics, Avrio Genetics, genomiQa Pty Ltd, DELFI Diagnostics, GENOME INSIGHT INC.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
23Strands and GenEmbryomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors 23Strands and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes